Skip to content
★ Sign in to follow
游

游洪涛

Directeur exécutif
华森制药
Insider activity · 24 months0 buys3 salesCumulative net flow
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€5.8M

Latest filing published 13 Jan 2026 for 华森制药, €2.1M.

Filing timeline

BuySale
游洪涛

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

游洪涛: trading record in brief

This profile gathers the share dealings of 游洪涛 in 华森制药, where the filings describe the role as chief executive. The record holds 3 filings, for trades running from 1 December 2025 to 13 January 2026.

On the market, this insider has only sold: 3 sales, €5.8M in total. 2026 to date brings no purchases and 1 sale.

The latest filing, published on 13 January 2026, reports an open-market sale of €2.1M in 华森制药. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Companies and markets linked to 游洪涛

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▼
    董事,高管Executives华森制药
    17M CNY11SZSE
    1,200,600 shares35.8% of flowA股XSHESZSE:273000000111619400
  • ▼
    董事,高管Executives华森制药
    28M CNY13SZSE
    2,043,800 shares60.0% of flowA股XSHESZSE:273000000016474880
  • ▼
    董事,高管Executives华森制药
    2M CNY7SZSE
    138,000 shares4.2% of flowA股XSHESZSE:173000009853526600

3 of 3 declarations